Bullfrog AI Holdings, Inc. (BFRG)

NASDAQ: BFRG · IEX Real-Time Price · USD
2.700
-0.320 (-10.60%)
At close: Apr 19, 2024, 3:59 PM
2.750
+0.050 (1.85%)
After-hours: Apr 19, 2024, 7:10 PM EDT
-10.60%
Market Cap 21.20M
Revenue (ttm) 65,000
Net Income (ttm) -5.36M
Shares Out 7.85M
EPS (ttm) -0.89
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 126,592
Open 3.010
Previous Close 3.020
Day's Range 2.690 - 3.012
52-Week Range 2.360 - 8.590
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date May 22, 2024

About BFRG

Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data. It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obe... [Read more]

Sector Healthcare
IPO Date Feb 14, 2023
Employees 11
Stock Exchange NASDAQ
Ticker Symbol BFRG
Full Company Profile

Financial Performance

In 2023, BFRG's revenue was $65,000, an increase of 550.00% compared to the previous year's $10,000. Losses were -$5.36 million, 91.1% more than in 2022.

Financial Statements

News

BullFrog AI Announces Availability of Fireside Chat Recording Featuring CEOs of BullFrog AI and the Lieber Institute

GAITHERSBURG, Md., March 08, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial ...

6 weeks ago - GlobeNewsWire

BullFrog AI Announces Underwriter's Decision to Exercise Over-Allotment Option to Purchase 218,382 Shares of the Company's Common Stock

GAITHERSBURG, Md., Feb. 21, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug development company using artificial in...

2 months ago - GlobeNewsWire

BullFrog AI to Discuss Findings from its Collaboration with Lieber Institute for Brain Development in Fireside Chat Hosted by RedChip

GAITHERSBURG, Md., Feb. 09, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial i...

2 months ago - GlobeNewsWire

WallachBeth Capital Announces Closing Of Bullfrog AI $5.7 Million Public Offering

JERSEY CITY, N.J. , Feb. 5, 2024 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today BullFrog AI Holdings, Inc. (NASDAQ...

2 months ago - PRNewsWire

BullFrog AI Announces Closing of $5.7 Million Public Offering

GAITHERSBURG, Md., Feb. 05, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial in...

2 months ago - GlobeNewsWire

WallachBeth Capital Announces Bullfrog AI Pricing of $5.7 Million Public Offering

JERSEY CITY, N.J. , Feb. 1, 2024 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that BullFrog AI Holdings, Inc. (N...

2 months ago - PRNewsWire

Bullfrog AI Announces Pricing of $5.7 Million Public Offering

GAITHERSBURG, Md., Feb. 01, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("Bullfrog AI" or the "Company"), a technology-enabled drug development company using artificial in...

2 months ago - GlobeNewsWire

BullFrog AI Strengthens Scientific Advisory Board with the Addition of Dr. Gwenn Smith and Dr. Jeremiah Wala

GAITHERSBURG, Md., Jan. 26, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial i...

3 months ago - GlobeNewsWire

This AI stock is up 30% on Wednesday: find out more

Bullfrog AI Holdings Inc (NASDAQ: BFRG) says early results of its work with the Lieber Institute for Brain Development have been positive. Its shares are up 35% at writing.

3 months ago - Invezz

BullFrog AI's Collaboration with Lieber Institute for Brain Development Yields Potentially Groundbreaking Biological Stratification of Brain Expression Data

GAITHERSBURG, Md., Jan. 17, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug development company using artificial i...

3 months ago - GlobeNewsWire

BullFrog AI Announces Issuance of Australian Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating Cancer

GAITHERSBURG, Md., Jan. 16, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial i...

3 months ago - GlobeNewsWire

BullFrog AI to Present at Webull LIVE! Healthcare Webinar on January 17

GAITHERSBURG, Md., Jan. 11, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial i...

3 months ago - GlobeNewsWire

BullFrog AI Issues Letter to Shareholders

GAITHERSBURG, Md., Dec. 29, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial i...

4 months ago - GlobeNewsWire

BullFrog AI Launches Preclinical Study to Investigate BF-114's Potential in Battling Obesity

The market for obesity drugs is projected to exceed $77 billion by 2030 Dr. Randy Seeley, a recognized expert on novel treatments for obesity, to lead study GAITHERSBURG, Md., Dec. 06, 2023 (GLOBE NEW...

4 months ago - GlobeNewsWire

ASP Isotopes and Bullfrog AI Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

ORLANDO, FL / ACCESSWIRE / October 27, 2023 / RedChip Companies will air interviews with ASP Isotopes Inc. (NASDAQ:ASPI) and BullFrog AI Holdings, Inc. (NASDAQ:BFRG)(NASDAQ:BFRGW) on The RedChip Small...

Other symbols: ASPI
6 months ago - Accesswire

BullFrog AI to Present at Benzinga All Access Event on October 20

GAITHERSBURG, Md., Oct. 18, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial i...

6 months ago - GlobeNewsWire

BullFrog AI Announces Identification of Novel Potential Drug Targets for Colorectal Cancer Using Its AI-Driven bfLEAP™ Platform

Discoveries generated by analyzing The Cancer Genome Atlas using proprietary bfLEAP™ platform Target validation will be conducted through partnership with J. Craig Venter Institute (JCVI), a world-lea...

7 months ago - GlobeNewsWire

BullFrog AI Founder and CEO Vin Singh to Present Company Overview at BioFuture 2023

GAITHERSBURG, Md., Sept. 25, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial ...

7 months ago - GlobeNewsWire

BullFrog AI Announces Launch of BullFrog Data Networks™, a Data Insights Tool Powered by the bfLEAP™ Platform

Purpose-built Data Product Offers Customized Visualization of Relationships and Pathways for Specific Disease Indications Built from High-dimension, Multi-modal Data Sets Purpose-built Data Product Of...

7 months ago - GlobeNewsWire

BullFrog AI Founder and CEO Vin Singh to Present Company Overview at Maxim Group's Emerging Growth in AI Virtual Tech Conference Series

GAITHERSBURG, Md., Sept. 14, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial ...

7 months ago - GlobeNewsWire

BullFrog AI Announces Three-Year Global Strategic Partnership with the Lieber Institute for Brain Development

The Strategic Collaboration will Leverage BullFrog AI's bfLEAP™ AI Platform to Accelerate R&D Initiatives, Including New Drug Target and Disease Biomarker Identification The Strategic Collaboration wi...

7 months ago - GlobeNewsWire

BullFrog AI Announces Investor Webinar with CEO and Founder Vin Singh on Thursday, September 14, 2023

GAITHERSBURG, Md., Sept. 07, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial ...

8 months ago - GlobeNewsWire

BullFrog AI Technology Licensed from Johns Hopkins University APL Named Finalist in R&D 100 Awards

Proprietary Machine Learning Technology Powering bfLEAP™ Drug Discovery Platform Among Best in IT/Electrical Category Proprietary Machine Learning Technology Powering bfLEAP™ Drug Discovery Platform A...

8 months ago - GlobeNewsWire

RedChip Launches 'Small Stocks, Big Money' Podcast

New podcast series shines a spotlight on undervalued small-cap and microcap stocks ORLANDO, FL / ACCESSWIRE / August 2, 2023 / RedChip Companies, a renowned international investor relations firm speci...

Other symbols: LTRNRVPHSTSSZOM
9 months ago - Accesswire

BullFrog AI Announces Issuance of U.S. Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating Cancer

Novel compounds show improved bioavailability relative to mebendazole Novel compounds show improved bioavailability relative to mebendazole

9 months ago - GlobeNewsWire